59 related articles for article (PubMed ID: 10894266)
1. BTK mediated apoptosis, a possible mechanism for failure to generate high titer retroviral producer clones.
Islam TC; Brandén LJ; Kohn DB; Islam KB; Smith CI
J Gene Med; 2000; 2(3):204-9. PubMed ID: 10894266
[TBL] [Abstract][Full Text] [Related]
2. Bruton's tyrosine kinase is not essential for LPS-induced activation of human monocytes.
Pérez de Diego R; López-Granados E; Pozo M; Rodríguez C; Sabina P; Ferreira A; Fontan G; García-Rodríguez MC; Alemany S
J Allergy Clin Immunol; 2006 Jun; 117(6):1462-9. PubMed ID: 16751014
[TBL] [Abstract][Full Text] [Related]
3. xid affects events leading to B cell cycle entry.
Brorson K; Brunswick M; Ezhevsky S; Wei DG; Berg R; Scott D; Stein KE
J Immunol; 1997 Jul; 159(1):135-43. PubMed ID: 9200448
[TBL] [Abstract][Full Text] [Related]
4. Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA.
Gaspar HB; Lester T; Levinsky RJ; Kinnon C
Clin Exp Immunol; 1998 Feb; 111(2):334-8. PubMed ID: 9486400
[TBL] [Abstract][Full Text] [Related]
5. Early arrest in B cell development in transgenic mice that express the E41K Bruton's tyrosine kinase mutant under the control of the CD19 promoter region.
Maas A; Dingjan GM; Grosveld F; Hendriks RW
J Immunol; 1999 Jun; 162(11):6526-33. PubMed ID: 10352268
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of the SH2-kinase linker region of Bruton's tyrosine kinase defines alternative modes of regulation for cytoplasmic tyrosine kinase families.
Guo S; Wahl MI; Witte ON
Int Immunol; 2006 Jan; 18(1):79-87. PubMed ID: 16291652
[TBL] [Abstract][Full Text] [Related]
7. Generation of a conditionally neo(r)-containing retroviral producer cell line: effects of neo(r) on retroviral titer and transgene expression.
Wildner O; Candotti F; Krecko EG; Xanthopoulos KG; Ramsey WJ; Blaese RM
Gene Ther; 1998 May; 5(5):684-91. PubMed ID: 9797874
[TBL] [Abstract][Full Text] [Related]
8. Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling.
Lindvall JM; Blomberg KE; Väliaho J; Vargas L; Heinonen JE; Berglöf A; Mohamed AJ; Nore BF; Vihinen M; Smith CI
Immunol Rev; 2005 Feb; 203():200-15. PubMed ID: 15661031
[TBL] [Abstract][Full Text] [Related]
9. Bruton's tyrosine kinase is dispensable for the Toll-like receptor-mediated activation of mast cells.
Zorn CN; Keck S; Hendriks RW; Leitges M; Freudenberg MA; Huber M
Cell Signal; 2009 Jan; 21(1):79-86. PubMed ID: 18848985
[TBL] [Abstract][Full Text] [Related]
10. The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages.
de Weers M; Verschuren MC; Kraakman ME; Mensink RG; Schuurman RK; van Dongen JJ; Hendriks RW
Eur J Immunol; 1993 Dec; 23(12):3109-14. PubMed ID: 8258324
[TBL] [Abstract][Full Text] [Related]
11. Reliable generation of stable high titer producer cell lines for gene therapy.
Rattmann I; Kleff V; Feldmann A; Ludwig C; Sorg UR; Opalka B; Moritz T; Flasshove M
Intervirology; 2007; 50(3):197-203. PubMed ID: 17283445
[TBL] [Abstract][Full Text] [Related]
12. Characterization of novel Bruton's tyrosine kinase gene mutations in Central European patients with agammaglobulinemia.
Kristufek D; Aspalter RM; Eibl MM; Wolf HM
Mol Immunol; 2007 Mar; 44(7):1639-43. PubMed ID: 17045652
[TBL] [Abstract][Full Text] [Related]
13. Promotion of photodynamic therapy-induced apoptosis by stress kinases.
Xue Ly; He J; Oleinick NL
Cell Death Differ; 1999 Sep; 6(9):855-64. PubMed ID: 10510467
[TBL] [Abstract][Full Text] [Related]
14. Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells.
Smith CI; Baskin B; Humire-Greiff P; Zhou JN; Olsson PG; Maniar HS; Kjellén P; Lambris JD; Christensson B; Hammarström L
J Immunol; 1994 Jan; 152(2):557-65. PubMed ID: 8283037
[TBL] [Abstract][Full Text] [Related]
15. Genotype-phenotype correlation in Bruton's tyrosine kinase deficiency.
Teimourian S; Nasseri S; Pouladi N; Yeganeh M; Aghamohammadi A
J Pediatr Hematol Oncol; 2008 Sep; 30(9):679-83. PubMed ID: 18776760
[TBL] [Abstract][Full Text] [Related]
16. Genomic organization of mouse and human Bruton's agammaglobulinemia tyrosine kinase (Btk) loci.
Sideras P; Müller S; Shiels H; Jin H; Khan WN; Nilsson L; Parkinson E; Thomas JD; Brandén L; Larsson I
J Immunol; 1994 Dec; 153(12):5607-17. PubMed ID: 7989760
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of Bruton's tyrosine kinase in B cell precursor leukemia cells.
Feldhahn N; Río P; Soh BN; Liedtke S; Sprangers M; Klein F; Wernet P; Jumaa H; Hofmann WK; Hanenberg H; Rowley JD; Müschen M
Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13266-71. PubMed ID: 16141323
[TBL] [Abstract][Full Text] [Related]
18. Characterization of germline mutations of the gene encoding Bruton's tyrosine kinase in families with X-linked agammaglobulinemia.
Hagemann TL; Rosen FS; Kwan SP
Hum Mutat; 1995; 5(4):296-302. PubMed ID: 7627183
[TBL] [Abstract][Full Text] [Related]
19. Role of Bruton's tyrosine kinase in macrophage apoptosis.
Khare A; Viswanathan B; Gund R; Jain N; Ravindran B; George A; Rath S; Bal V
Apoptosis; 2011 Apr; 16(4):334-46. PubMed ID: 21193961
[TBL] [Abstract][Full Text] [Related]
20. Bruton's tyrosine kinase prevents activation of the anti-apoptotic transcription factor STAT3 and promotes apoptosis in neoplastic B-cells and B-cell precursors exposed to oxidative stress.
Uckun F; Ozer Z; Vassilev A
Br J Haematol; 2007 Feb; 136(4):574-89. PubMed ID: 17367410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
